Spero Therapeutics Inc — 貸借対照表 (NASDAQ:SPRO) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 153.45 M171.07 M124.8 M182.39 M110.54 M68.92 M 負債合計 21.41 M82.78 M48.87 M75.5 M64.42 M9.9 M 純資産合計 132.04 M88.29 M75.93 M106.89 M46.12 M59.02 M 負債および純資産合計 153.45 M171.07 M124.8 M182.39 M110.54 M68.92 M 有利子負債合計 177 K138 K96 K87 K091 K 純負債 -118.89 M-138.93 M-102.36 M-70.7 M-48.59 M-37.28 M

ニュース

Spero Therapeutics: Tebipenem’s FDA Path Supports A Speculative Buy (NASDAQ:SPRO)

キューツァー氏、Spero Therapeutics COOが44,000ドル相当の株式を売却

Keutzer, Spero Therapeutics COO, sells $44k in shares

スペロ・セラピューティクスのCEOが20万7千ドル相当の株式を売却

Spero Therapeutics CEO sells $207k in stock

GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook

Spero Therapeutics announces board resignation and SEC investigation closure

GSK files NDA resubmission for Spero’s tebipenem HBr antibiotic

【決算速報】Spero Therapeutics Inc、売上高は予想を下回り、利益は予想を上回る結果に

Spero Therapeutics earnings beat by $0.26, revenue fell short of estimates

スペロ・セラピューティクスのCEOラジャベル氏、9.5万ドル相当の株式を売却

Spero therapeutics CEO Rajavelu sells $95k in stock